Anticipate Ventures works closely with and in between inventors, entrepreneurs, corporates, National Labs, universities, hospitals and investors to improve their tech transfer opportunities. Innovative technologies are often deemed too risky for end users to fund. Anticipate Ventures reduces the risks for both innovators and prospective commercialization partners by incubating innovation with the right strategic plan, resources, network, environment, investment and small business contract or grant funding to complete the critical research, development and demonstration milestones needed to reduce the risks associated with commercializing the technologies.
Providing unparalleled disinfection for defense, schools, healthcare, transit systems and more
Earth abundant high efficiency catalyst technologies for hydrogen production
Commercial and residential real estate
An outsourcing marketplace for research and development equipment and services
Our current innovation portfolio is concentrated in Healthcare, Clean Technology, Autonomous Vehicles, AgTech, E-commerce, FinTech and Artificial Intelligence.
Previous successful ventures/exits include:
Aspen Aerogels www.aerogel.com insulation nanotechnology (IPO - NYSE:ASPN)
QM Power www.qmpower.com electric motors (Acquisition - Private Equity)
Genalytic pharmacogenomics
Sign up to hear from us about specials, sales, and events.
7208 Wornall Rd,Suite 220, Kansas City, MO